1. P 90 Clinical feasibility of novel ultra-sensitive multiplex NfL, Tau, UCHL-1 and GFAP assay for evaluation of neuro-axonal and glial damage in serum samples of patients with multiple sclerosis using reduced cost protocol. (May 2022) Authors: Dargvainiene, J.; Junker, R.; Stürner, K.H.; Wandinger, K.P.; Markewitz, R.; Leypoldt, F. Journal: Clinical neurophysiology Issue: Volume 137(2022) Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The effect of enamel matrix derivative (Emdogain®) on gene expression profiles of human primary alveolar bone cells. (11th June 2012) Authors: Yan, X. Z.; Rathe, F.; Gilissen, C.; van der Zande, M.; Veltman, J.; Junker, R.; Yang, F.; Jansen, J. A.; Walboomers, X. F. Journal: Journal of tissue engineering and regenerative medicine Issue: Volume 8:Number 6(2014:Jun.) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗